Advertisement

Tumoren von Trachea, Bronchien, Lunge, Pleura und Mediastinum

  • H. Toomes
  • I. Vogt-Moykopf
  • H. H. Vollhaber

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Batata MA, Martini N, Huvos AG, Aguilar RJ, Beattie EJ (1974) Thymomas: Clinicopathologic features. Therapy and prognosis. Cancer 34:389PubMedCrossRefGoogle Scholar
  2. Bauer KH (1963) Das Krebsproblem. 2. Aufl. Springer, Berlin Gottingen HeidelbergCrossRefGoogle Scholar
  3. Bitran JD, Desser RK, De Meester TR et al. (1976) Cyclophosphamide, adriamycin, methotrexate and procarbazine (CAMP). Effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma. Cancer Treat Rep 60:1225PubMedGoogle Scholar
  4. Bleehen NM (1980) Management of inoperable squamous cell adeno- and large cell carcinoma. In: Hansen HH, Rorth M (eds) Lung cancer II world conference, Copenhagen. Excerpta Medica, Amsterdam, p 93Google Scholar
  5. Broder LE, Cohen MH, Selawry OS (1977) Treatment of bronchogenic carcinoma II small cell. Cancer Treat Rev 4:219PubMedCrossRefGoogle Scholar
  6. Butler TP, MacDonald JS, Smith FP, Smith LF, Wooley PV, Schein PS (1979) 5-Fluorouracil, adriamycin and mitomycin-C (FAM) chemotherapy for adenocarcinoma of the lung. Cancer 43:1183PubMedCrossRefGoogle Scholar
  7. Chahinian AP, Mandel EM, Holland JF, Jaffrey IS, Teirstein As (1979) MACC (methotrexate, adriamycin, cyclophosphamide and CCNU) in advanced lung cancer. Cancer 43:1590PubMedCrossRefGoogle Scholar
  8. Chahinian AP (1980) Chemotherapy of lung cancer (all types except small cell). In: Chahinian AP, Hansen HH (eds) Cancer clinic series. Meyers, Bristol, pp 12–26Google Scholar
  9. Cohen MH, Creaven PJ, Fossieck BE et al. (1977) Intensive chemotherapy of small cell bronchogenic carcinoma. Cancer Treat Rep 61:349PubMedGoogle Scholar
  10. Coy P (1978) Curative radiotherapy in lung cancer. Int J Radiat Oncol Biol Phys [Suppl 2] 4:72Google Scholar
  11. Drings P, Dirks P, Manke HG, Vollhaber HH, Queisser W (1980) Vorlaufige Erfahrungen mit der Kombination Ifosfamid-Cisplatin beim nichtkleinzelligen Bronchialkarzinom. In: Burkert H, Nagel GA (Hrsg) Neue Erfahrungen mit Oxazaphosphorinen unter besonderer Beriicksichtigung des Uroprotektors Uromitexan®. Karger, Basel Munchen Paris London New York Sydney, S 77Google Scholar
  12. Eagan RT, Frytak S, Creagan ET, Ingle JN, Kvols LK, Coles DT (1979) Phase II study of cyclophosphamide, adriamycin, and cisdichlorodiammine-platinum (II) by infusion in patients with adenocarcinoma and large cell carcinoma of the lung. Cancer Treat Rep 63:1589PubMedGoogle Scholar
  13. Gall FP, Muhe E, Angermann B (1979) Chirurgische Behandlung von Lungenmetastasen. Dtsch Med Wochenschr 104:835PubMedCrossRefGoogle Scholar
  14. Goldhirsch A, Joss R, Alberto P, Cavalli F, Brunner KW (1980) Cisplatinum (DDP) and VP-16–213 (VP) combination with and without adriamycin (ADM) in the treatment of lung cancer. Proc Assoc Cancer Res Am Soc Clin Oncol (ASCO Abstr C 514) 21:449Google Scholar
  15. Gralla RJ, Casper ES, Kelsen DP, Golbey RB (1980) Vindesine (DVA) and cisplatin (DDP) combination chemotherapy in non-small cell cancer (NSCLC): A two-year follow-up. In: Hansen HH, Dombernowsky P (eds) II World conference on lung cancer. Excerpta Medica, Amsterdam Oxford Princeton, p 229Google Scholar
  16. Greco FA, Richardson RL, Schulman SF, Stroup SL, Oldham RK (1978) Treatment of oat cell carcinoma of the lung: complete remission, acceptable complications and improved survival. Br Med J 2:10PubMedCrossRefGoogle Scholar
  17. Grunze H (1962) Tumoren der Thoraxorgane. In: Bartelheimer H, Maurer HJ (Hrsg) Diagnostik der Geschwulstkrankheiten. Thieme, StuttgartGoogle Scholar
  18. Hansen HH (1980) Management of small cell anaplastic carcinoma. In: Hansen HH, Rorth M (eds) II World conference on lung cancer. Excerpta Medica, Amsterdam Oxford Princeton, p 113Google Scholar
  19. Havemann K, Gropp C, Gassel WD et al. (1980) Treatment of small cell lung cancer with a new combination chemotherapy consisting of VP 16–213, Ifosphamide, and Vindesine (AlO-Study BI). In: Hansen HH, Dombernowsky P (eds) II World conference on lung cancer. Excerpta Medica, Amsterdam Oxford Princeton, p 152Google Scholar
  20. Heilmann HP et al. (1976) Ergebnisse der Strahlenbehandlung des Bronchialkarzinoms. Dtsch Med Wochenschr 101:1557PubMedCrossRefGoogle Scholar
  21. Hyde LJ, Yee R, Wilson M, Pattno E (1965) Cell type and the natural history of lung cancer. JAMA 193:140CrossRefGoogle Scholar
  22. Johnson RE, Brereton HD, Kent CH (1976) Small cell carcinoma of the lung. Attempt to remedy causes of past therapeutic failure. Lancet 1:289CrossRefGoogle Scholar
  23. Kaplan EL, Meier P (1980) In: Kalbfleisch JD, Prentice RL (eds) The statistical analysis of failure time data. J Wiley, New YorkGoogle Scholar
  24. Lanzotti VJ, Berry RJ, Newmann CR, Smith P (1975) Treatment of small cell carcinoma of bronchus. Lancet 1:129Google Scholar
  25. Liesenfeld A, Havemann K, Gropp C et al. (im Druck) Behandlung des kleinzelligen Bronchialkarzinoms mit zwei neuen Chemotherapiekombinationen (AlO-Studien BI u. II). Verh Dtsch Ges Inn Med 87Google Scholar
  26. Livingston RB, Moore TN, Heilbrun L, Bottomley R, Lehane D, Rivkin SE, Thigpen T (1978) Small cell carcinoma of the lung. Combined chemotherapy and radiation. A south-west group study. Ann Intern Med 88:194PubMedGoogle Scholar
  27. Livingston RB (1981) Small cell lung carcinoma recent advances and current challenges. In: Carter SK, Sakurai Y, Umezawa H (eds) New drugs in cancer chemotherapy. Recent results in cancer research 76. Springer, Berlin Heidelberg New York, p 266Google Scholar
  28. Longeval E, De Jager R, Tagnon H, Klastersky J (1980) Cisplatin (CDDP)-VP 16–213 combination chemotherapy in non-small cell (NSC) bronchogenic carcinoma: phase I-II clinical trial. Proc Am Assoc Cancer Res Am Soc Clin Oncol (ASCO Abstr C 195) 21:368Google Scholar
  29. Merrin C, Takita H, Beckley S, Kassis J (1977) Treatment of recurrent and widespread testicular tumor by radical reductive surgery and multiple sequential chemotherapy. J Urol 117:291PubMedGoogle Scholar
  30. Mountain CF, Hermes KH (1979) Management implications of surgical staging studies. In: Muggia F, Rozencweig M (eds) Lung cancer: Progress in therapeutic research. Raven, New York, Vol II, p 233Google Scholar
  31. Mountain CF (1980) Surgery of lung cancer including adjunctive therapy. In: Hansen HH, Rorth M (eds) Lung cancer 1980 II World conference Copenhagen. Excerpta Medica, Amsterdam, p 71Google Scholar
  32. Niederle N, Schilcher RB, Bierbaum W, Mouratidou D, Seeber S, Schmidt DG (1980 a) Erste Ergebnisse mit dem ACO II-Protokoll beim inoperablen kleinzelligen Bronchialkarzinom. Verh Dtsch Ges Inn Med 86:464Google Scholar
  33. Niederle N, Schmidt CG, Seeber S (1980 b) Nichtoperative Therapie des Bronchialkarzinoms. Intern Welt 10:359Google Scholar
  34. Seeber S, Schmidt CG, Holfeld H, Scherer E (1977) Integrate Behandlung (Chemotherapie und Radiotherapie) des inoperablen Bronchialkarzinoms, vorlaufige Ergebnisse bei 50 Patienten. Dtsch Med Wochenschr 102:147PubMedCrossRefGoogle Scholar
  35. Selikoff IJ, Churg J, Hammond EC (1965) Relation between exposure to asbestos and mesothelioma. N Engl J Med 272:560PubMedCrossRefGoogle Scholar
  36. Shehata WM (1977) Role of radiation therapy in bronchogenic carcinoma. Ohio State Med J 73:605PubMedGoogle Scholar
  37. Sierocki JS, Hilaris BJ, Hopfan S, Martini N, Barton D, Golbey RB, Wittes RB (1979) Cis-Diamminedichloroplatinum II and VP 16; an active induction regimen for small cell carcinoma of the lung. Cancer Treat Rep 63:1593PubMedGoogle Scholar
  38. Sobin LH (1977) The WHO histological classification of lung tumors. In: Wilkinson PM (ed) Clinical cancer principle sites 2. Pergamon, Oxford New York (Advances in medical oncology research and education, vol 11, p 5)Google Scholar
  39. Toomes H, Delphendahl A, Manke HG, Vogt-Moykopf I (1981 a) Differentialdiagnose und Beurteilung des solitaren ungenrundherdes. Dtsch Aerztebl 37:1717Google Scholar
  40. Toomes H, Manke HG, Vogt-Moykopf I, Drings P (1981) Eingriffe bei Lungenmetastasen. Chirurg 52:21PubMedGoogle Scholar
  41. UICC (1979) TNM-Klassifikation der malignen Tumoren, 3. uberarb erweit Aufl. Springer, Berlin Heidelberg New YorkGoogle Scholar
  42. Vogt-Moykopf I (1974) Gefaßplastiken bei Bronchusmanschetten-Resektion. Prax Pneumol 28:1030PubMedGoogle Scholar
  43. Vogt-Moykopf I, Zeidler D (1978) Palliativoperationen an Lunge und Pleura. Med Klin 73:341PubMedGoogle Scholar
  44. Vogt-Moykopf I, Zeidler D (1980) Tumoren von Trachea, Bronchien und Lunge. In: Scheibe O, Wagner G, Bokelmann D (Hrsg) Krebsnachsorge. Urban & Schwarzenberg, S 201Google Scholar
  45. Vogt-Moykopf I, Lüllig H, Toomes H (1980) Operativer Stand und Moglichkeiten beim Bronchialkarzinom. Onkologie 3:112PubMedCrossRefGoogle Scholar
  46. Vogt-Moykopf I, Lüllig H, Toomes H, Weidauer H (1980) Tracheaersatz am Menschen, kombinierte Eingriffe an Bronchien und Gefa Ben der Lunge. Langenbecks Arch Chir 352:285CrossRefGoogle Scholar
  47. Vogt-Moykopf I, Abel U, Heinrich St, Toomes H, Wesch H (im Druck) Organsparende Operationsverfahren beim Bronchialkarzinom, Ergebnisse. Langenbecks Arch ChirGoogle Scholar
  48. Weiss RB (1978) Small cell carcinoma of the lung. Therapeutic management. Ann Intern Med 88:522PubMedGoogle Scholar
  49. Williams DE, Pairolero PC, Davis CS et al. (1981) Survival of patients surgically treated for stage I lung cancer. J Thorac Cardiovasc Surg 82:70PubMedGoogle Scholar
  50. Yap BS, Benjamin RS, Burgess MA, Bodey GP (1978) The value of adriamycin in the treatment of diffuse malignant pleural mesothelioma. Cancer 42:1692PubMedCrossRefGoogle Scholar
  51. Yessner R (1973) Observer variability and reliability in lung cancer diagnosis. Cancer Chemother Rep 4:55Google Scholar
  52. Zeidler D (1980) Die Mediastinaltumoren. Dtsch Ges Chir 3:1980Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1982

Authors and Affiliations

  • H. Toomes
  • I. Vogt-Moykopf
  • H. H. Vollhaber

There are no affiliations available

Personalised recommendations